Cart
sales@molnova.com
SAH
CAS No. 979-92-0
SAH( SAH (S-Adenosylhomocysteine) )
Catalog No. M21671 CAS No. 979-92-0
SAH is an inhibitor for the METTL3-METTL14 heterodimer complex (METTL3-14 IC50: 0.9 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 26 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSAH
-
NoteResearch use only, not for human use.
-
Brief DescriptionSAH is an inhibitor for the METTL3-METTL14 heterodimer complex (METTL3-14 IC50: 0.9 μM).
-
DescriptionSAH is an inhibitor for the METTL3-METTL14 heterodimer complex (METTL3-14 IC50: 0.9 μM).
-
In Vitro——
-
In Vivo——
-
SynonymsSAH (S-Adenosylhomocysteine)
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number979-92-0
-
Formula Weight384.41
-
Molecular FormulaC14H17N6O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO: 125 mg/mL (325.17 mM; Need ultrasonic)
-
SMILESN[C@@H](CCSC[C@@H]1[C@]([C@]([C@](N2C=NC3=C2N=CN=C3N)O1)O)O)C(O)=O
-
Chemical Name(5S)-2-amino-5-((2S3S4R5R)-5-(6-amino-9H-purin-9-yl)-34-dihydroxytetrahydrofuran-2-yl)-5-mercaptopentanoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.DE LA HABA G et al. The enzymatic synthesis of S-adenosyl-L-homocysteine from adenosine and homocysteine. J Biol Chem. 1959 Mar;234(3):603-8.
molnova catalog
related products
-
PROT-IN-1
PROT-IN-1 is a potent high-affinity inhibitor of L-proline transporter and a candidate compound for the treatment of neurological diseases.
-
A2ti-1
A2ti-1 is a highly selective inhibitor of annexin A2/S100A10 heterotetramer (A2t) (IC50: 24 μM) that inhibits ARV-mediated activation of Src and p38 mitogen-activated protein kinase (MAPK).
-
GR 64349
Potent and selective tachykinin NK2 receptor agonist (EC50 = 3.7 nM in rat colon). Displays > 1000- and > 300-fold selectivity over NK1 and NK3 receptors respectively. Active in vivo.
